Testicular Cancer

Leydig Cell Hyperplasia and Childhood Mumps: A Case Report November 24, 2021

Narrative review of developing new biomarkers for decision making in advanced testis cancer. November 24, 2021

Seasonal Variations in the Diagnosis of Testicular Germ Cell Tumors: A National Cancer Registry Study in Austria. November 23, 2021

Management of stage I testicular cancer. November 19, 2021

Contemporary options and future perspectives: three examples highlighting the challenges in testicular cancer imaging. November 18, 2021

Therapy of clinical stage IIA and IIB seminoma: a systematic review. November 17, 2021

Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND). November 8, 2021

Outcomes of retroperitoneal lymph node dissection for testicular cancer by a high volume surgeon from Australia: a case for centralisation. November 4, 2021

Outcomes of Postchemotherapy Retroperitoneal Lymph Node Dissection from a High-volume UK Centre Compared with a National Data Set. November 3, 2021

Domestic use of pesticides during early periods of development and risk of testicular germ cell tumors in adulthood: a French nationwide case-control study. November 2, 2021

Validation of testicular germ cell tumor staging in nationwide cancer registries. November 1, 2021

Cisplatin, environmental metals, and cardiovascular disease: an urgent need to understand underlying mechanisms. October 29, 2021

Prophylaxis Against Thromboembolic Events During Chemotherapy for Germ Cell Cancer. October 28, 2021

Thromboembolic Events During Treatment with Cisplatin-based Chemotherapy in Metastatic Testicular Germ-cell Cancer 2000-2014: A Population-based Cohort Study. October 27, 2021

Nerve-sparing Robot-assisted Retroperitoneal Lymph Node Dissection: The Monoblock Technique. October 26, 2021

Combining Hypermethylated RASSF1A Detection Using ddPCR with miR-371a-3p Testing: An Improved Panel of Liquid Biopsy Biomarkers for Testicular Germ Cell Tumor Patients. October 25, 2021

Rapid Response to Pembrolizumab in a Chemo-Refractory Testicular Germ Cell Cancer with Microsatellite Instability-High. October 15, 2021

A Multi-institutional Pooled Analysis Demonstrates That Circulating miR-371a-3p Alone is Sufficient for Testicular Malignant Germ Cell Tumor Diagnosis. October 14, 2021

Quality of life among germ-cell testicular cancer survivors: The effect of time since cancer diagnosis. October 11, 2021

Perceived Positive and Negative Life Changes in Testicular Cancer Survivors. October 6, 2021

Page 1 of 74

email news signup